This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for March 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amerisafe's (AMSF) Q4 Earnings Miss as Revenues Decline
by Zacks Equity Research
Amerisafe's (AMSF) earnings suffer from a decline in revenues and increase in expenses.
Marsh & McLennan (MMC) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Decent performance across segments is likely to drive Marsh & McLennan's (MMC) fourth-quarter results.
What's in Store for MetLife (MET) This Earnings Season?
by Zacks Equity Research
MetLife's (MET) earnings should be driven by higher contribution from its U.S. EMEA, Latin America businesses, partly offset by lower net income from the Asia unit.
Will Weak Japan Business Hurt Aflac's (AFL) Q4 Earnings?
by Zacks Equity Research
Aflac's (AFL) earnings should see a dent from weak Japan business but be partially aided by strength in its U.S. business.
Will Annuities Unit Aid Lincoln National (LNC) Q4 Earnings?
by Zacks Equity Research
Lincoln National's (LNC) earnings are likely to benefit from higher annuity sales, strong Retirement and Life insurance business.
Aflac (AFL) Hits New 52-Week High: Is More Upside Left?
by Zacks Equity Research
Aflac (AFL) gains on estimated positive impact of tax reform but further upside seems muted.
Why You Shouldn't Bet Against AMERISAFE (AMSF) Stock
by Zacks Equity Research
AMERISAFE, Inc. (AMSF) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Is Amerisafe (AMSF) a Great Stock for Value Investors?
by Zacks Equity Research
Is Amerisafe (AMSF) a great pick from the value investor's perspective right now? Read on to know more.
Why the Earnings Streak Will Continue for Amerisafe (AMSF)
by Zacks Equity Research
Amerisafe (AMSF) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
Amerisafe Maintains Niche Position in High Hazard Insurance
by Zacks Equity Research
Amerisafe's (AMSF) niche presence in workers' compensation insurance market operating high-hazard industries makes it a specialty insurer.
Unum (UNM) Rides High on Growth Prospects: Time to Buy?
by Zacks Equity Research
Unum (UNM) appears an attractive pick on the back of growth projections and upward estimate revisions.
The Zacks Analyst Blog Highlights: Primerica, Amerisafe, Employers Holdings and Unum Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Primerica, Amerisafe, Employers Holdings and Unum Group
4 Solid Insurance Stocks to Hit High Spots in Q4 Bull Market
by Zacks Equity Research
We close in on four insurance stocks likely to perform well in Q4, riding high on core strengths.
Amerisafe (AMSF) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Earnings growth and lower expenses are reflected in Amerisafe's (AMSF) Q3 performance.
Will Revenue Growth Aid Marsh & McLennan (MMC) Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter earnings are likely to benefit from strong contribution by both its operating segments.
Key Predictions for Q3 Earnings Reports of AFL, UNM, AMSF
by Zacks Equity Research
The third quarter witnessed a slew of catastrophes, which will weigh on underwriting profitability as well as the bottom line of insurers.
Will Visa (V) Q4 Earnings Buoy Up on Better Payment Volumes?
by Zacks Equity Research
Visa (V) fourth-quarter earnings likely to benefit from increased payments volumes, lower client incentives and accelerated share buyback among other factors.
Will Strong U.S. Business Aid Aflac's (AFL) Q3 Earnings?
by Zacks Equity Research
Aflac's (AFL) third-quarter earnings are likely to benefit from strong contribution by its U.S. segment, partly offset by weakness in its Japan business.
Is a Beat in the Cards for Progressive (PGR) in Q3 Earnings?
by Zacks Equity Research
An improving top line might help Progressive (PGR) exceed estimates this earnings season.
Aflac Well Poised on U.S. Unit, Currency Volatility Hurts
by Zacks Equity Research
Aflac's (AFL) strong U.S. business impresses but its large exposure to Japan exposes it to low interest woes and foreign exchange volatility.
Allstate Hits 52-Week High on Strong Results, Expansion Plan
by Zacks Equity Research
Allstate (ALL) hits 52-week high on second-quarter results, increase in share buyback authorization and expansion plans.
MetLife Suffers From Declining Revenues, Spinoff Charges
by Zacks Equity Research
MetLife's (MET) declining revenues, low premiums, fees and other revenues continue to bother.
Amerisafe (AMSF) Q2 Earnings Beat Estimates, Decrease Y/Y
by Zacks Equity Research
Declining revenues hurt Amerisafe's (AMSF) profitability in Q2 earnings.
Aflac (AFL) Q2 Earnings Beat Estimates, Guidance Intact
by Zacks Equity Research
Aflac's (AFL) better-than-expected results were driven by favorable performance in its U.S. segment, partly offset by foreign currency movement.